About AristaMD
AristaMD is a private company based in San Diego, California. It has reported $54,160,717 raised in 16 offerings on Form D since August 2014. Its chief executive is Brooke LeVasseur.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 27, 2021 | Mar 7, 2022 | $10,267,999fully sold | 7 | $1.4M | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 20, 2020 | Mar 31, 2020amended Jul 21, 2020 | $22,000,000fully sold | 7 | $3.1M | Equity, Debt, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Feb 25, 2020 | Feb 28, 2020 | $1,000,000fully sold | 1 | $1.0M | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jun 21, 2019 | Oct 4, 2019 | $1,500,000fully sold | 1 | $1.5M | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 7, 2019 | May 28, 2019 | $1,500,000fully sold | 1 | $1.5M | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Feb 7, 2019 | Feb 13, 2019 | $500,000fully sold | 1 | $500K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Dec 12, 2018 | Dec 17, 2018 | $1,000,000fully sold | 1 | $1.0M | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Oct 15, 2018 | Oct 25, 2018 | $1,000,000fully sold | 1 | $1.0M | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jun 29, 2018 | Jul 10, 2018 | $1,000,000fully sold | 1 | $1.0M | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Dec 22, 2017 | Mar 30, 2018 | $2,900,000fully sold | 1 | $2.9M | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Sep 6, 2017 | Sep 18, 2017 | $1,000,000fully sold | 1 | $1.0M | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jun 29, 2017 | Jul 12, 2017 | $1,000,000fully sold | 1 | $1.0M | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| May 20, 2016 | Jun 1, 2016 | $4,604,219of $7.0M target | 2 | $2.3M | EquityRule 506(b) | Form D ↗ |
| Mar 15, 2016 | Mar 23, 2016 | $1,375,000fully sold | 2 | $687K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Nov 20, 2015 | Dec 15, 2015 | $1,375,000fully sold | 2 | $687K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jul 31, 2014 | Aug 15, 2014 | $2,138,499of $4.0M target | 6 | $356K | Equity, Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, 16 offerings | $54,160,717 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on AristaMD's Form D filed Mar 7, 2022.
Earlier filings also listed David Eichler (director, last listed Nov 2023), Thomas Cooper (director, last listed Feb 2020), Michael Scarbrough (director, last listed Feb 2020), Jay Lichter (director, last listed Feb 2020), Michael Scarborough (director, last listed Mar 2018), Rebecca Cofinas (president & ceo, director, last listed Jun 2016), Lesley Young (director, last listed Mar 2016) and Douglas Downs (executive officer and director, last listed Aug 2014).